Ipca Laboratories Limited
IPCALAB
Helyezés a részvények között
#3410
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Részvényárfolyam
$20.00
Utolsó szinkronizálás: 2026-10-19
Piaci kapitalizáció
$5.08B
Változás (1 nap)
-1.76%
Változás (1 év)
38.31%
Ország
IN
Kereskedés Ipca Laboratories Limited (IPCALAB)
Kategória
Healthcare
EPS Ipca Laboratories Limited (IPCALAB) részvényre
EPS June 2026 dátummal, TTM: $0.57
Ipca Laboratories Limited legfrissebb pénzügyi jelentései és részvényára alapján a vállalat jelenlegi EPS mutatója (TTM) $0.57. 2024 végén a vállalat EPS mutatója $0.26 volt, növekedés a 2023 év EPS értékéhez, amely $0.23 volt.
Ipca Laboratories Limited EPS története 2005 és 2026 között
EPS minden év végén
| Év | EPS | Változtassa meg |
|---|---|---|
| 2026 (TTM) | $0.57 | 67.59% |
| 2025 | $0.34 | 31.43% |
| 2024 | $0.26 | 14.42% |
| 2023 | $0.23 | -50.75% |
| 2022 | $0.46 | -25.34% |
| 2021 | $0.61 | 93.12% |
| 2020 | $0.32 | 25.55% |
| 2019 | $0.25 | 73.94% |
| 2018 | $0.15 | 22.62% |
| 2017 | $0.12 | 113.46% |
| 2016 | $0.06 | -65.49% |
| 2015 | $0.16 | -48.97% |
| 2014 | $0.32 | 34.08% |
| 2013 | $0.24 | 8.86% |
| 2012 | $0.22 | -7.87% |
| 2011 | $0.24 | 28.52% |
| 2010 | $0.18 | 131.65% |
| 2009 | $0.08 | -41.78% |
| 2008 | $0.14 | 16.48% |
| 2007 | $0.12 | 111.05% |
| 2006 | $0.06 | -18.58% |
| 2005 | $0.07 | 0.00% |
EPS hasonló cégek vagy versenytársak esetén
| Vállalat | EPS | EPS különbség | Ország |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -2.37% |
IN
|
